Atea Pharmaceuticals Inc. (AVIR) Social Stream
ATEA PHARMACEUTICALS INC (AVIR) Price Targets From Analysts
Use the tables below to see what analysts covering ATEA PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-12 | 5 | $20 | $14 | $16.666 | $3.37 | 394.54% |
| 2021-11-18 | 5 | $16 | $11 | $13.666 | $3.37 | 305.52% |
| 2021-12-15 | 4 | $16 | $11 | $13.666 | $3.37 | 305.52% |
| 2022-01-04 | 4 | $14 | $10 | $11.666 | $3.37 | 246.17% |
| 2022-01-06 | 4 | $11 | $7 | $9.333 | $3.37 | 176.94% |
| 2022-01-31 | 4 | $11 | $6 | $9 | $3.37 | 167.06% |
| 2022-02-15 | 4 | $10 | $6 | $8.666 | $3.37 | 157.15% |
| 2022-02-28 | 4 | $10 | $6 | $8.333 | $3.37 | 147.27% |
| 2022-05-10 | 4 | $9 | $6 | $7.666 | $3.37 | 127.48% |
| 2022-08-09 | 4 | $11 | $6 | $8.666 | $3.37 | 157.15% |
| 2022-08-15 | 4 | $12 | $7 | $9.333 | $3.37 | 176.94% |
| 2022-10-12 | 3 | $12 | $7 | $9 | $3.37 | 167.06% |
| 2022-11-08 | 4 | $12 | $7 | $9 | $3.37 | 167.06% |
| 2023-01-24 | 4 | $12 | $4 | $8 | $3.37 | 137.39% |
| 2023-03-01 | 4 | $12 | $4 | $7.333 | $3.37 | 117.6% |
The Trend in the Analyst Price Target
Over the past 27 months, AVIR's average price target has gone down $39.67.
Over the past 46 weeks, AVIR's average upside potential has been 49.51%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-04-12 | 4 | 9 | 6 | 7.666 | 6.55 | 17.04% |
| 2022-05-16 | 4 | 11 | 6 | 8.666 | 7.51 | 15.39% |
| 2022-08-09 | 4 | 12 | 6 | 9.000 | 8.48 | 6.13% |
| 2022-08-15 | 4 | 12 | 7 | 9.333 | 8.58 | 8.78% |
| 2022-09-19 | 4 | 12 | 7 | 9.000 | 6.31 | 42.63% |
AVIR Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.68 | 1 | 0 | 2 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
AVIR's average broker recommendation rating improved by 0.25 over the prior 30 weeks.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for AVIR as an investment opportunity.
- In the context of all US stocks, ATEA PHARMACEUTICALS INC's average analyst price target is higher than 164.45% of them.
- AVIR has a greater number of analysts covering the stock than 257.53% of all US stocks.
- AVIR has a higher upside potential (average analyst target price relative to current price) than 1331.75% of stocks in the mid market cap category.
- AVIR has a lower variance in analysts' estimates than -538.01% of Pharmaceutical Products stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to ATEA PHARMACEUTICALS INC are LMDX, RXDX, and EQRX.
View All Top Stocks by Price Target
Make investment decisions regarding AVIR using the data that counts. Try POWR Ratings for free.